Skip to content

CNTACENTESSA PHARMACEUTICALS LTD

CUSIP 152309100 · depositary receipt

No tracked investor reported shares of CENTESSA PHARMACEUTICALS LTD (CNTA) for Q2 2026. 5 investors sold out this quarter, including Perceptive Advisors.

Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding CNTA · Q2 2026

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Perceptive Advisors4.08%5,258,903$208.9MEXIT
Lee Ainslie0.85%1,854,488$73.7MEXIT
Julian Baker0.15%670,751$26.6MEXIT
Chuck Royce0.11%278,064$11MEXIT
Adar1 Capital Management0.09%38,566$1.5MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q2 2026005$0—
Q1 2026500$321.8M$39.72
Q4 2025500$140.9M$25.01